PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
28.40%
Positive revenue growth while CVE is negative. John Neff might see a notable competitive edge here.
81.45%
Gross profit growth at 50-75% of CVE's 134.13%. Martin Whitman would question if cost structure or brand is lagging.
60.76%
EBIT growth above 1.5x CVE's 5.76%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
60.76%
Operating income growth above 1.5x CVE's 5.76%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
59.63%
Net income growth above 1.5x CVE's 21.13%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
59.49%
EPS growth above 1.5x CVE's 18.75%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
59.66%
Diluted EPS growth above 1.5x CVE's 25.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.28%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
0.28%
Dividend growth of 0.28% while CVE is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
45.84%
Positive OCF growth while CVE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
164.79%
Positive FCF growth while CVE is negative. John Neff would see a strong competitive edge in net cash generation.
-39.31%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-3.54%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-5.17%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-55.53%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
4.46%
Positive OCF/share growth while CVE is negative. John Neff might see a comparative advantage in operational cash viability.
46.32%
Positive 3Y OCF/share CAGR while CVE is negative. John Neff might see a big short-term edge in operational efficiency.
-730.97%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
34.70%
Below 50% of CVE's 83.20%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-101.34%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-87.41%
Negative equity/share CAGR over 10 years while CVE stands at 6.59%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-59.50%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-57.18%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-90.72%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-59.95%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
28.73%
Our short-term dividend growth is positive while CVE cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-14.75%
Firm’s AR is declining while CVE shows 22.08%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-4.54%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-11.59%
We have a declining book value while CVE shows 1.06%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-1.95%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-77.70%
We cut SG&A while CVE invests at 200.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.